載入...
CD4+ count‐dependent concentration–effect relationship of rituximab in rheumatoid arthritis
AIMS: Rituximab is approved in rheumatoid arthritis (RA). A substantial decrease in CD4+ count was observed in responders after a single cycle of treatment. This study aimed to describe and quantifying the influence of CD4+ count depletion on the concentration–response relationship of rituximab in R...
Na minha lista:
| 發表在: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6955400/ https://ncbi.nlm.nih.gov/pubmed/31454097 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14102 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|